1. Petersen J, Dandri M, Gupta S, et al. 1998 Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc Natl Acad Sci U S A 95:310-5.
2. Dandri M, Burda MR, Zuckerman DM, et al. 2005 Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J Hepatol 42:54-60.
3. Dandri M, Burda MR, Torok E, et al. 2001 Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33:981-8.
4. Busuttil RW, Farmer DG. 1996 The surgical treatment of primary hepatobiliary malignancy. Liver Transpl Surg 2:114-30.
5. Lake JR. 1998 Hepatocyte transplantation. N Engl J Med 338:1463-5.
6. Grossman M, Raper SE, Kozarsky K, et al. 1994 Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 6:335-41.
7. Nussler A, Konig S, Ott M, et al. 2006 Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 45:144-59.
8. Allen KJ, Soriano HE. 2001 Liver cell transplantation: the road to clinical application. J Lab Clin Med 138:298-312.
9. Sgroi A, Serre-Beinier V, Morel P, et al. 2009 What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation 87:457-66.
10. Sato Y, Yamada H, Iwasaki K, et al. 2008 Human hepatocytes can repopulate mouse liver: histopathology of the liver in human hepatocyte-transplanted chimeric mice and toxicologic responses to acetaminophen. Toxicol Pathol 36:581-91.
11. Matas AJ, Sutherland DE, Steffes MW, et al. 1976 Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science 192:892-4.
12. Groth CG, Arborgh B, Bjorken C, et al. 1977 Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation.
Transplant Proc 9:313-6.
13. Gupta S, Rajvanshi P, Sokhi R, et al. 1999 Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 29:509-19.
14. Rajvanshi P, Kerr A, Bhargava KK, et al. 1996 Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents.
Gastroenterology 111:1092-1102.
15. Ponder KP, Gupta S, Leland F, et al. 1991 Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 88:1217-21.
16. Zhang H, Miescher-Clemens E, Drugas G, et al. 1992 Intrahepatic hepatocyte transplantation following subtotal hepatectomy in the recipient: a possible model in the treatment of hepatic enzyme deficiency. J Pediatr Surg 27:312-5; discussion 315-6.
17. Kokudo N, Ohashi K, Takahashi S, et al. 1994 Effect of 70% hepatectomy on DNA synthesis in rat hepatocyte isograft into the spleen. Transplant Proc 26:3464-5.
18. Rabes HM, Wirsching R, Tuczek HV, et al. 1976 Analysis of cell cycle compartments of hepatocytes after partial hepatecomy. Cell Tissue Kinet 9:517-32.
19. Grisham JW. 1962 A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3.
Cancer Res 22:842-9.
20. Bucher NL, Swaffield MN. 1964 The Rate of Incorporation of Labeled Thymidine into the Deoxyribonucleic Acid of Regenerating Rat Liver in Relation to the Amount of Liver Excised. Cancer Res 24:1611-25.
21. Laconi E, Oren R, Mukhopadhyay DK, et al. 1998 Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 153:319-29.
22. Laconi S, Pillai S, Porcu PP, et al. 2001 Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol 158:771-7.
23. Lieber A, Peeters MJ, Gown A, et al. 1995 A modified urokinase plasminogen activator induces liver regeneration without bleeding. Hum Gene Ther 6:1029-37.
24. van Rooijen N, van Nieuwmegen R. 1984 Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study. Cell Tissue Res 238:355-8.
25. Heckel JL, Sandgren EP, Degen JL, et al. 1990 Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 62:447-56.
26. Sandgren EP, Palmiter RD, Heckel JL, et al. 1991 Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66:245-56.
27. Rhim JA, Sandgren EP, Degen JL, et al. 1994 Replacement of diseased mouse liver by hepatic cell transplantation. Science 263:1149-52.
28. Rhim JA, Sandgren EP, Palmiter RD, et al. 1995 Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci U S A 92:4942-6.
29. Shinkai Y, Rathbun G, Lam KP, et al. 1992 RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-67.
30. Mercer DF, Schiller DE, Elliott JF, et al. 2001 Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7:927-33.
31. Fausto N. 2001 A mouse model for hepatitis C virus infection? Nat Med 7:890-1.
32. Walter E, Keist R, Niederost B, et al. 1996 Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24:1-5.
33. Kock J, Baumert TF, Delaney WEt, et al. 2003 Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 38:1410-8.
34. Novacek MJ. 1992 Mammalian phylogeny: shaking the tree. Nature 356:121-5.
35. Guitart A, Riezu-Boj JI, Elizalde E, et al. 2005 Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-kappaB nuclear translocation. J Gen Virol 86:3065-74.
36. Dandri M, Burda MR, Gocht A, et al. 2001 Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation. Hepatology 34:824-33.
37. Petersen J, Dandri M, Mier W, et al. 2008 Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 26:335-41.
38. Dandri M, Murray JM, Lutgehetmann M, et al. 2008 Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia. Hepatology 48:1079-86.
39. Vanwolleghem T, Libbrecht L, Hansen BE, et al. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. J Hepatol 53:468-76.
40. Wittwer CT, Ririe KM, Andrew RV, et al. 1997 The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22:176-81.
41. Kawahara T, Toso C, Douglas DN, et al. Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl 16:974-82.
42. Fausto N, Campbell JS. 2003 The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120:117-30.
43. Meuleman P, Libbrecht L, De Vos R, et al. 2005 Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41:847-56.
44. Tateno C, Kataoka M, Utoh R, et al. Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Endocrinology 152:1479-91.
45. Tateno C, Yoshizato K. 1996 Growth and differentiation in culture of clonogenic hepatocytes that express both phenotypes of hepatocytes and biliary epithelial cells. Am J Pathol 149:1593-605.
46. Yamasaki C, Tateno C, Aratani A, et al. 2006 Growth and differentiation of colony-forming human hepatocytes in vitro. J Hepatol 44:749-57.